An official website of the United States government

Here's how you know

U.S. Department of Health and Human Services National Institutes of Health

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

NIH is not accepting Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) applications because the legislative authority for the programs expired on October 1, 2025. Active awardees should direct any questions to their Program Officer. See NOT-OD-26-006.

Modulation Therapeutics

Modulation Therapeutics is a clinical-stage company dedicated to bringing novel therapeutics to the treatment of cancer patients. Its lead molecule, MTI-201, is currently in a Phase I clinical trial; another is in development, called MTI-301. The company is developing a potent and specific inhibitor of SCD1 for the treatment of hepatocellular cancer and fatty liver disease (NASH). These indications demonstrate increased incidence worldwide, and novel treatments are required to improve patient outcomes.

Company Ownership: Woman Owned

Contact Name:

Lori Hazlehurst

Contact Email:

[email protected]

Website: https://www.modulationtherapeutics.com/

City, State – Congressional District: Morgantown,

–

Technology: Drug

Funding: Cancer (NCI)

NIH Projects: NIH RePorter for Modulation Therapeutics

Sponsored Event(s): MedCity INVEST 2024 | 2024